Texas A&M University has been named a 2026 Fast Company World Changing Ideas honoree, earning national recognition for its innovative regenerative heart patch. The award, presented in the Academic Excellence category, places Texas A&M among the top 100 projects globally that are tackling the world’s most urgent challenges with creative solutions.
According to the announcement from Fast Company, “These schools are not only making rapid advances in sustainability, design and healthcare but are pioneering spaces where students can experiment and design with hands-on, ideas-oriented approaches — driving the next generation of changemakers.”
Fast Company’s annual World Changing Ideas Awards celebrate projects that have the potential to profoundly impact society. This year’s competition drew more than 1,500 entries, with winners selected by a team of editors and writers for their ingenuity, scalability and potential for real-world change.
People are also reading…
Texas A&M is honored for its healing heart patch alongside LEGO Education, Johns Hopkins Applied Physics Lab, Tin Can, Yondr and NuCycle. In the Academic Excellence category, Texas A&M is joined by MIT and the Savannah College of Art and Design.
“At Texas A&M, we are committed to research that doesn’t just advance knowledge, but transforms lives,” said Texas A&M President Susan Ballabina. “Our researchers are driven to bring world-changing ideas to life, turning breakthrough ideas into tangible solutions that positively impact our state, our nation and our world.”
Transforming heart attack recovery
The patch was developed by Texas A&M researcher Dr. Ke Huang and may offer a way to help the heart heal after a heart attack. The patch uses a unique microneedle system to deliver a therapeutic molecule directly to damaged heart tissue, promoting repair and improving heart function without affecting the rest of the body.
Each tiny needle in this biodegradable patch contains microscopic particles loaded with interleukin-4 (IL-4), a molecule known to help regulate the immune system. When applied to the surface of the heart, the needles dissolve and release IL-4 directly into the injured area, creating a healing-friendly environment.
“This patch acts like a bridge,” said Huang, assistant professor in the Department of Pharmaceutical Sciences within the Irma Lerma Rangel College of Pharmacy. “The microneedles penetrate the outer layer of the heart and allow the drug to reach the damaged muscle underneath, which is normally very hard to access.”
By delivering IL-4 directly to the site of injury, the patch encourages immune cells called “macrophages” to switch from a pro-inflammatory state to a healing state. This shift helps reduce scar formation and improves the final prognosis.
“Macrophages are the key,” Huang explained. “They can either make inflammation worse or help the heart heal. IL-4 helps turn them into helpers.”
The biodegradable patch is designed to integrate with damaged cardiac tissue, providing structural support while delivering targeted therapeutic cues that encourage regeneration at the cellular level. Using artificial intelligence to help optimize the material’s design and performance, the team is accelerating development of a smarter, more precise solution — one that moves recovery from generalized treatment to targeted repair.
